A new diagnostic development is positioning the swine industry closer to faster, more precise respiratory disease management—addressing one of the most persistent challenges in production systems today.
Researchers at Purdue University have developed a targeted next-generation sequencing (NGS) panel capable of detecting and differentiating a wide range of viral and bacterial pathogens from a single diagnostic sample.
The innovation represents a significant step forward in simplifying how producers and veterinarians approach respiratory disease, particularly in environments where co-infections are common and difficult to isolate.
At the core of the technology is a parallel sequencing approach that enables the simultaneous analysis of multiple nucleic acid fragments—from both the host and potential pathogens—within one test. This allows for a comprehensive pathogen profile without the need for multiple, sequential diagnostics.
One Test, Full Picture
The panel targets approximately 25 pathogens, including key industry challenges such as:
- PRRS
- Influenza A
- PCV2 and PCV3
- Mycoplasma hyopneumoniae
- Streptococcus suis
- Glaesserella parasuis
- Actinobacillus pleuropneumoniae (APP)
By consolidating detection into a single test, the approach addresses a long-standing inefficiency in swine health management—where multiple tests are often required to fully understand a disease event.
Tackling the Complexity of Co-Infections
Respiratory disease in swine production is rarely driven by a single pathogen. Co-infections are common, complicating both diagnosis and treatment decisions.
This new sequencing panel is designed to:
- Identify multiple pathogens simultaneously
- Support more targeted treatment decisions
- Reduce reliance on repeated or sequential testing
- Provide earlier insight into emerging or unknown pathogens
The ability to detect both viral and bacterial contributors in one step is expected to enhance decision-making at both the veterinary and operational level.
A Shift Toward Precision Health Management
As production systems continue to evolve, so does the need for more precise, data-driven health strategies. Tools like this NGS panel signal a shift toward integrated diagnostics that align with modern production demands—where speed, accuracy, and efficiency are critical.
Beyond immediate disease identification, this approach also opens the door to:
- Improved herd-level health monitoring
- Faster response times during disease events
- More strategic use of treatments and interventions
Looking Ahead
This development reinforces a broader industry trend: moving from reactive diagnostics toward predictive and precision-based health management.
For producers, the implication is clear—better diagnostics lead to better decisions, and ultimately, more consistent performance across the system.
As tools like this continue to evolve, the ability to understand the full disease landscape from a single sample may become the new standard in swine health management.
